Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Eliquis 5 mg film-coated tablets, Waran 2,5 mg tabletter, OPTISON 0.19 mg/ml dispersion for injection, SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, Eliquis 2.5 mg film-coated tablets
The George Institute
Left ventricular thrombosis., Acute mycocardial infarction (AMI)
1 trial -
Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge
The George Institute
Perianal fistula associated with Crohn's disease
1 trial -
Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection
The George Institute
Coronary artery chronic total occlusion
1 trial -
FLUNARIZINE , TOPIRAMATE , AMITRIPTYLINE , PROPRANOLOL
The George Institute
Migraine
1 trial -
FOSFOMYCIN
The George Institute
Uncomplicated urinary tract infection (uUTI)
1 trial -
Ferinject 50 mg/ml dispersión inyectable y para perfusión
The George Institute
Anemia in patients with chronic ischemia of the lower limb ischemia
1 trial -
Ferinject 50 mg/ml dispersión inyectable y para perfusión
The George Institute
Acute coronary syndrome
1 trial -
Fluad Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted), Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Vaxigrip injektioneste, suspensio, esitäytetty ruisku. Kolmivalenttinen influenssarokote (virusfragmentit, inaktivoitu)., Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuva
The George Institute
Avian influenza and seasonal influenza
1 trial -
Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable
The George Institute
Cardiovascular device infections
1 trial -
Fludex 1,5 mg, επικαλυμμένα με λεπτό υμένιο δισκία παρατεταμένης αποδέσμευσης., LUCIDEL 150 mg επικαλυμμένα με λεπτό υμένιο δισκία., Amlopen® 5mg καψάκια σκληρά, Inosamin 25mg, επικαλυμμένα με λεπτό υμένιο δισκία
The George Institute
Hypertension
1 trial -
Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
The George Institute
Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV
1 trial -
HUMAN SERUM ALBUMIN, SODIUM CHLORIDE
The George Institute
descompensated hepatic cirrosis
1 trial -
HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.
The George Institute
Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).
1 trial -
HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE
The George Institute
Rheumatoid Arthritis
1 trial -
INDOCYANINE GREEN
The George Institute
Patients with liver tumors that will undergo minimally invasive liver surgery
1 trial -
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
The George Institute
Influenza, Immunity against influenza
1 trial -
Iomeron 400 mgI/ml solution for injection
The George Institute
Thoracic neoplasm
1 trial -
KENACORT 40 mg/ml sospensione iniettabile, Suero Fisiológico Braun 0,9% disolvente para uso parenteral Cloruro de sodio, Lidocaína B. Braun 20 mg/ml solución inyectable, BUPIVACAÍNA PHYSAN 0,25% SOLUCIÓN INYECTABLE
The George Institute
TRAPEZIUS MYOFASCIAL SYNDROME IN FIBROMYALGIA PATIENTS
1 trial -
LINEZOLID, LINEZOLID
The George Institute
Sepsis
1 trial -
LIVTENCITY 200 mg film-coated tablets.
The George Institute
Transplant patients with high recurrent Epstein-Barr infection
1 trial -
Levobupivacaína Normon 5 mg/ml solución inyectable y para perfusión EFG, Inibsacain 5 mg/ml + 0,005 mg/ml solución inyectable en cartucho
The George Institute
Hip fracture
1 trial -
Lixiana 30 mg film-coated tablets, Lixiana 60 mg film-coated tablets
The George Institute
High risk atrial fibrillation patients with previous intracranial hemorrhage
1 trial -
Metformin Actavis 500 mg filmdragerad tablett
The George Institute
Polycystic ovary syndrome
1 trial -
Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule
The George Institute
lumbosacral radiculalgia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources